Literature DB >> 6258827

Radioimmunoassay of extracted glucagon compared with three non-extraction assays.

H von Schenck, O R Nilsson.   

Abstract

Radioimmunoassay of glucagon was performed with three different antisera, i.e. E7, 30K and 4305, all directed against the carboxyl-terminal region of glucagon and thus avoiding co-determination of glucagon-like polypeptides from the gut. Plasma samples from five healthy people subjected to various A-cell stimulation and suppression tests were used and immunoreactive glucagon assessed with the three antisera. Aliquots from all plasma samples were also extracted with acetone and glucagon re-assessed with antiserum E7. Even though all four baseline glucagon concentrations obtained were different, the glucagon profiles were comparable after superimposing the baselines. The differences in baseline concentrations of immunoreactive glucagon seem due to the interference of "big plasma glucagon", a still unidentified factor in the E7 and 30K assays that can be precipitated by acetone. Since acetone extraction yielded the lowest baselines without altering the glucagon profiles, it is suggested that the baseline glucagon concentrations of acetone-extracted plasma reflect the physiological level of the biologically active hormone. Using antiserum E7, our own antiserum, the normal range of glucagon values in acetone-extracted plasma samples from 22 healthy, fasting people of both sexes was 42 +/- 16 ng/l (mean +/- 2 S.D.). These values agree well with those obtained by other assay techniques.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6258827     DOI: 10.1016/0009-8981(81)90333-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

Authors:  S Attvall; J Fowelin; H von Schenck; I Lager; U Smith
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

2.  Bilateral thoracoscopic splanchnicectomy: effects on pancreatic pain and function.

Authors:  I Ihse; E Zoucas; E Gyllstedt; R Lillo-Gil; A Andrén-Sandberg
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

3.  Effects of chronic sodium salicylate feeding on the impaired glucagon and epinephrine responses to insulin-induced hypoglycaemia in streptozotocin diabetic rats.

Authors:  D G Patel; K A Skau
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

4.  The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth.

Authors:  F Jockenhövel; S Lederbogen; T Olbricht; H Schmidt-Gayk; E P Krenning; S W Lamberts; D Reinwein
Journal:  Clin Investig       Date:  1994-01

5.  Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Authors:  I Lager; H von Schenck; U Smith
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

6.  Increase in plasma free fatty acids and natriuresis by xanthines may reflect adenosine antagonism.

Authors:  K E Andersson; N Johannesson; B Karlberg; C G Persson
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

7.  Longitudinal changes of plasma pancreatic enzymes and hormones in experimental pancreatolithiasis in dogs.

Authors:  T Hayakawa; T Kondo; T Shibata; M Kitagawa; H Sobajima; Y Sakai; H Ishiguro; Y Nakae; M Tanikawa; S Naruse
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

8.  Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.

Authors:  K P Ohman; L Weiner; H von Schenck; B E Karlberg
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation.

Authors:  S Attvall; B M Eriksson; J Fowelin; H von Schenck; I Lager; U Smith
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

10.  Hormone glucagon: electrooxidation and determination at carbon nanotubes.

Authors:  Sushma Karra; Wendell P Griffith; Robert T Kennedy; Waldemar Gorski
Journal:  Analyst       Date:  2016-03-03       Impact factor: 4.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.